CHUGAI INNOVATION CHALLENGE
SHAPING THE FUTURE OF TELEMEDICINE AND TREATMENT MANAGEMENT

CONTEXT

The COVID-19 pandemic accelerated the growth and acceptance of telemedicine.

How to increase the diagnostic capacity of healthcare professionals in remote consultations? 

Non-adherence to medical treatments is a well-known issue for modern medicine, costing every year a lot of lives and money to healthcare plans and pharmaceutical companies, lacking feedback from their end-users.

How to increase adherence from patients in oncology, haemophilia and rheumatology treatment?

METHODOLOGY

Hello Tomorrow worked with the Chugai team to organize the challenge and sourcing:

  1. Framing, including specific topics and value proposition for startups
  2. Sourcing relevant startups
  3. Communication campaign, global and targeted, throughout the challenge
  4. Application platform operation and selection process for the jury
  5. Final selection to join the second phase of the Global Pharma Booster acceleration programme with Digital Pharma Lab

RESULTS

Within 3 months, from the first framing meeting to the second phase of the Global Pharma booster programme:

  • A tailor-made brochure produced by our graphic designer as well as dedicated application platform
  • 500 startups identified meeting the eligibility criteria
  • 70 startup applications
  • 10 Chugai experts involved in the jury, equipped with the Hello Tomorrow evaluation forms and grids
  • 15 finalists selected to take part in a last round of selection with the jury & Hello Tomorrow (70% coming from the existing Hello Tomorrow network)
  • 1 winner and ongoing collaboration

Social Media Sharing